Health authorities urge clinicians to check vaccination status and watch for chronic or worsening wounds, especially in ...

Europe has seen a resurgence of diphtheria since 2022, with cutaneous forms predominating in vulnerable groups and declining adult vaccination rates in adults.

A groundbreaking study from Zambia has shed new light on one of the deadliest threats to infants in low-resource regions—fatal acute febrile illness (fAFI). Researchers have identified distinct ...

Live probiotics like Bacillus coagulans act as natural peacekeepers. They survive the harsh journey through toothpaste formulation because they exist in spore form a protective shell that resists ...

In May 2023, the Human Pangenome Reference Consortium (HPRC) released the first draft of the human pangenome reference ...

Mortality was strongly associated with older age, comorbidities, and infection type, underscoring the need for early and diagnosis-specific antimicrobial intervention.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Trained immunity is reshaping our understanding of host defense by demonstrating that innate immune cells once thought to lack memory can be reprogrammed to mount heightened responses to subsequent ...

According to Towards FnB, the global probiotics animal feed market size is evaluated at USD 5.44 billion in 2025 and is anticipated to hit USD 11.72 billion by 2034. This sustained rise represents an ...

DelveInsight's Antibody-mediated Rejection Market Insights report includes a comprehensive understanding of current treatment ...

The antibody-mediated rejection market is expanding as the number of organ transplants rises and awareness of AMR's impact on graft survival grows. Advances in diagnostic assays ...